Cellnovo Group

Cellnovo Group S.A.
Stock Exchange Euronext Paris
EPS
EUR0.98
Market Cap
EUR2.26 M
Shares Outstanding
17.64 M
Public Float
11.25 M

Profile

Address
13, rue de Londres
Paris Ile-de-France 75009
France
Employees -
Website http://www.cellnovo.com
Updated 07/08/2019
Cellnovo Group SA is a medical technology company, which specializes in diabetes. The company develops and markets the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. Its products portfolio includes system, switch, pump therapy, and patient stories.

Financials

View All

Sophie Baratte
Chief Executive Officer & Director
Pierre Chancel
Director